Business Context and Reporting Period
This Form 8-K reports on the Annual General Meeting of Shareholders held by InMed Pharmaceuticals Inc. on December 19, 2023. The company is incorporated in British Columbia and its common shares trade on The Nasdaq Stock Market LLC under the symbol INM. The filing is designated as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
Shareholders voted in favor of all items of business presented at the meeting. The specific results were:
- Proposal 1 (Election of Directors): All five nominees were elected to serve until the 2024 Annual General Meeting.
- Eric A. Adams: 76.09% For (160,711 votes)
- Andrew Hull: 66.94% For (141,398 votes)
- Janet Grove: 67.17% For (141,882 votes)
- Bryan Baldasare: 68.96% For (145,659 votes)
- Nicole Lemerond: 69.06% For (145,865 votes)
Each nominee received 1,081,422 broker non-votes.
- Proposal 2 (Appointment of Auditor): Shareholders approved the appointment of Marcum LLP as the independent registered public accounting firm.
- Votes For: 90.45% (1,169,259 votes)
- Votes Against: 0% (0 votes)
- Abstain: 123,387 votes
Guidance, Outlook, and Risks
The filing includes a Regulation FD disclosure referencing a press release issued on December 19, 2023, regarding the voting results. The document does not provide management commentary on future guidance, operational outlook, specific risks, contingencies, or unusual items beyond the standard governance disclosures.
Investor Verification Checklist
- Verify the tenure of the newly elected directors, which extends until the 2024 Annual General Meeting.
- Confirm the engagement of Marcum LLP as the independent auditor for the upcoming fiscal period.
- Note the significant number of broker non-votes (1,081,422) on the director election, which may indicate institutional holdings where brokers lacked discretionary voting power.
- Review the referenced press release (Exhibit 99.1) for any additional context on shareholder sentiment not detailed in the 8-K text.